Improving obstetric fistula care in Africa: The case for regenerative medicine

Kirubel T. Hailu(1), Tigist W. Leulseged(2),


(1) University College Cork, Cork, Ireland
(2) Medical Research Lounge (MRL), Addis Ababa, Ethiopia
Corresponding Author

Abstract


Obstetric fistula remains one of the most neglected maternal health conditions, with >500,000 women untreated and 50,000-100,000 new cases annually, mostly in sub-Saharan Africa and South Asia. Its consequences, chronic incontinence, infections, infertility, and stigma, are devastating. Surgical repair is the cornerstone of care, but a shortage of trained surgeons limits access, and outcomes are suboptimal: recurrence occurs in up to 20%, and up to one-third have persistent incontinence. These realities highlight the urgent need for adjunctive therapeutic strategies alongside surgery

References


Nations U. Intensifying efforts to end obstetric fistula within

a decade [Internet]. Vol. 11731. 2022. Available from:

https://www.unfpa.org/resources/intensifying-efforts

end-obstetric-fistula-within-decade-report-secretary

general-a77229

Panés J, Bouma G, Ferrante M, Kucharzik T, Nachury M, de

la Portilla de Juan F, Reinisch W, Selvaggi F,

Tschmelitsch J, Brett NR, Ladouceur M, Binek M,

Hantsbarger G, Campbell-Hill S, Karki C and Buskens

C. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel

in Patients With Perianal Fistulizing Crohn’s Disease

Treated in the ADMIRE-CD Trial. Inflamm Bowel

Dis. 2022;28(11):1737–45.

Panés J, García-Olmo D, Van Assche G, Colombel JF,

Reinisch W, Baumgart DC, Dignass A, Nachury M,

Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la

Portilla F, Goldin E, Richard MP, Leselbaum A,

Danese S and ADMIRE CD Study Group

Collaborators.. Expanded allogeneic adipose-derived

mesenchymal stem cells (Cx601) for complex perianalfistulas in Crohn’s disease: a phase 3 randomised,

double-blind controlled trial. The Lancet.

;388(10051):1281–90.

Guillo L, Gravier Dumonceau R, Vélier M, Serrero M,

Grimaud F, Sabatier F and Magalon J. Efficacy of

mesenchymal stem cell-based therapies in the

treatment of perianal fistulizing Crohn’s disease: a

systematic review and meta-analysis. Stem Cell

Research and Therapy [Internet]. 2025;16(1).

Available from: https://doi.org/10.1186/s13287-025

-y.


Full Text: PDF

Article Metrics

Abstract View : 339 times
PDF Download : 183 times

Refbacks

  • There are currently no refbacks.